CLCN3 and inflammatory bowel disease: CLC‐3 is expressed in both the ileum and colon, and its deficiency may be involved in the pathogenesis of inflammatory bowel disease (IBD) by promoting intestinal epithelial cell apoptosis and Paneth cell loss.